Global Automated Insulin Delivery System Market Size Estimated to Cross USD 2496 Million By 2030, Growing at a CAGR of 8.2% | Infinium Global Research

Infinium Global Research, a leading provider of insightful market research reports, has published a comprehensive report on the Global Automated Insulin Delivery System Market. This report offers an in-depth analysis of various segments and sub-segments within the global and regional automated insulin delivery system market. It also delves into the influence of drivers, restraints, and macro indicators on the market's short-term and long-term prospects. The global automated insulin delivery system market was valued at USD 1334 Million in 2022 and is expected to reach USD 2496 Million by 2030 and grow at a CAGR of 8.2% over the forecast period.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/6058

An automated insulin delivery system, known by various names such as a hybrid closed-loop system, artificial pancreas, bionic pancreas, and predictive low glucose suspend system, is designed to streamline insulin delivery for individuals with diabetes. It leverages continuous glucose monitors (CGMs) and intelligent algorithms to autonomously determine and adjust insulin delivery through a pump. The primary objective of these systems is to reduce or eliminate hypoglycemia (low blood sugar), remove the need for user input in insulin dosing, improve the time-in-range for blood glucose levels, and reduce hyperglycemia (high blood sugar).

In type 1 diabetes, the immune system attacks and destroys the beta cells in the pancreas, which are responsible for insulin production. The absence of insulin results in elevated blood sugar levels, potentially leading to diabetic coma and causing the body to use fat stores and muscle for energy. Thus, maintaining blood sugar levels for individuals with type 1 diabetes requires continuous monitoring. Automated insulin delivery systems rely on a transmitter attached to a tiny needle under the skin to continuously track glucose levels, a pump that delivers precise insulin doses via a separate catheter inserted under the skin, and a computer chip that uses data from both components to optimize insulin delivery. These systems provide individuals with type 1 diabetes the freedom to live their lives without the need for constant manual monitoring and insulin administration.

The growing global prevalence of diabetes is a significant driving force for the automated insulin delivery system market. According to the World Health Organization (WHO), the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. This increasing prevalence has led to a greater demand for advanced insulin delivery systems to simplify insulin uptake. Moreover, ongoing research and development efforts to produce innovative insulin delivery systems and awareness campaigns by various companies are further accelerating market growth. However, technological challenges, such as difficulties with glucose sensor calibration, sensor durability, and skin-related issues, may limit the adoption of automated insulin delivery systems. On the bright side, lenient regulatory approvals and enhanced technical clarity for device usage among patients provide significant growth opportunities.

The automated insulin delivery system market is segmented regionally into North America, Europe, Asia Pacific, and the Rest of the World. Currently, North America dominates the market, primarily due to the presence of top manufacturers and substantial investments in research and development to enhance existing insulin pumps and develop new products. The European market is expected to witness steady growth in the forecast period. In the near future, developing countries in Asia-Pacific, such as India, China, and Japan, are projected to experience high compound annual growth rates (CAGR) owing to a large diabetic patient pool and substantial investments in the healthcare sector.

The global automated insulin delivery system market report covers segments based on disease type and end-user. Disease type sub-segments include type I diabetes and type II diabetes. End-user sub-segments comprise hospital pharmacies, retail pharmacies, and diabetes clinics.

The report profiles key companies in the market, including Medtronic plc, Eli Lilly and Company, Tandem Diabetes Care, Inc., Insulet Corporation, Bigfoot Biomedical, Inc., Diabeloop SA, and others.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/6058

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Automated Insulin Delivery System Market Highlights

2.2. Automated Insulin Delivery System Market Projection

2.3. Automated Insulin Delivery System Market Regional Highlights

Chapter 3. Global Automated Insulin Delivery System Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Disease Type

3.4.2. IGR-Growth Matrix Analysis by End User

3.4.3. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Automated Insulin Delivery System Market

Chapter 4. Automated Insulin Delivery System Market Macro Indicator Analysis

Chapter 5. Global Automated Insulin Delivery System Market by Disease Type

5.1. Type I Diabetes

5.2. Type II Diabetes

Chapter 6. Global Automated Insulin Delivery System Market by End User

6.1. Hospital Pharmacies

6.2. Retail Pharmacies

6.3. Diabetes Clinics

Chapter 7. Global Automated Insulin Delivery System Market by Region 2023-2030

7.1. North America

7.1.1. North America Automated Insulin Delivery System Market by Disease Type

7.1.2. North America Automated Insulin Delivery System Market by End User

7.1.3. North America Automated Insulin Delivery System Market by Country

7.2. Europe

7.2.1. Europe Automated Insulin Delivery System Market by Disease Type

7.2.2. Europe Automated Insulin Delivery System Market by End User

7.2.3. Europe Automated Insulin Delivery System Market by Country

7.3. Asia-Pacific

7.3.1. Asia-Pacific Automated Insulin Delivery System Market by Disease Type

7.3.2. Asia-Pacific Automated Insulin Delivery System Market by End User

7.3.3. Asia-Pacific Automated Insulin Delivery System Market by Country

7.4. RoW

7.4.1. RoW Automated Insulin Delivery System Market by Disease Type

7.4.2. RoW Automated Insulin Delivery System Market by End User

7.4.3. RoW Automated Insulin Delivery System Market by Sub-region

Chapter 8. Company Profiles and Competitive Landscape

8.1. Competitive Landscape in the Global Automated Insulin Delivery System Market

8.2. Companies Profiles

8.2.1. Medtronic plc

8.2.2. Eli Lilly and Company

8.2.3. Tandem Diabetes Care, Inc.

8.2.4. Insulet Corporation

8.2.5. Bigfoot Biomedical, Inc.

8.2.6. Other companies

Chapter 9. Appendix

9.1. Primary Research Findings and Questionnaire

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/6058

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of automated insulin delivery system.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.